Latest filing published 31 Mar 2026 for Vaxart, Inc., €1,855. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James F. Cummings is a declared insider of Vaxart, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 13 filings cover trades dated from 28 March 2022 to 28 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 31 March 2026: a share grant of €1,855, in Vaxart, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations